Contract Research Organization WCCT Global Announces Innovative Addition to Their RMT for Clinical Patient Recruitment

August 29, 2013

WCCT Global is continually growing its capabilities for clinical patient recruitment with a new element that allows to pinpoint patient populations based on medical history. This is in addition to their robust Recruitment Management Tool.

Costa Mesa, California (PRWEB) August 29, 2013

WCCT Global, a contract research organization headquartered in Southern California announces today that they have added an innovative piece of technology to their already robust clinical patient recruitment system. This piece of technology enables WCCT Global to locate patient populations in specific geographical locations based on medical history and physician activity for the desired specific patient population based on the study inclusion/exclusion criteria. Lee Barsky, VP of Global Clinical Development exclaimed:

“This new technology is a great addition to the RMT because WCCT Global will not only be able to reach out to physicians in the areas located with specific patient populations but we can also implement a social media advertisement and engagement strategy to pinpoint the heavily populated areas of the specific patient populations to recruit for the clinical study – and the best part is all of this is with patients that are prequalified based on the IE criteria of the study."

The RMT was built upon a social media platform and having the ability to pinpoint patient population through electronic healthcare data sources, WCCT Global’s RMT now has even more targeted approach for clinical patient recruitment. With this ability, sponsors can have proven data around their site placement to increase their success in recruiting patients into studies.

More about WCCT Global

WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.

If you would like to request information about how WCCT Global can assist your organization with patient recruitment or a clinical study, please click here.

For the original version on PRWeb visit: http://www.prweb.com/releases/2013/8/prweb11071061.htm

Source: prweb

comments powered by Disqus